Shattuck Labs, Inc. STTK
5.15 USD -0.32 (-5.85%)
At closeNov 4, 2026, 4:44 PM EST
5.25 +0.10 +1.94%
After hours · Nov 4, 4:44 PM ET
5.10 Day range 5.72
1.72 52-week range 8.33
- YTD
- +41.10%
- 1 year
- +166.84%
News
defenseworld.net Comparing Shattuck Labs (NASDAQ:STTK) & Exicure (NASDAQ:XCUR) Shattuck Labs (NASDAQ: STTK - Get Free Report) and Exicure (NASDAQ: XCUR - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two…
globenewswire.com Shattuck Labs Announces Two Poster Presentations at UEG Week 2026 AUSTIN, Texas and DURHAM, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of…
benzinga.com UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17 UBS analyst Alice Nettleton initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Buy rating and announces Price Target of $17.
defenseworld.net Shattuck Labs (NASDAQ:STTK) Stock Falls 5.3% – Should You Sell? Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) shares fell 5.3% during mid-day trading on Monday. The company traded as low as $6.33 and last traded at $6.3760. 599,094 shares traded hands…
benzinga.com Wedbush Maintains Outperform on Shattuck Labs, Raises Price Target to $14 Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and raises the price target from $11 to $14.
benzinga.com Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday Analysts raised targets for ACN, SYNA, ATRC and MPC; cut targets for CSX, NKE, MKC and FHTX, with ATRC downgraded to Hold.
defenseworld.net Shattuck Labs (NASDAQ:STTK) Shares Climb 11.9% – Here’s Why Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report)'s stock price traded up 11.9% on Wednesday. The stock traded as high as $6.89 and last traded at $7.3150. 221,063 shares were traded during…- benzinga.com Needham Maintains Buy on Shattuck Labs, Raises Price Target to $19 Needham analyst Joseph Stringer maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $17 to $19.
defenseworld.net Comparing MDxHealth (NASDAQ:MDXH) & Shattuck Labs (NASDAQ:STTK) Shattuck Labs (NASDAQ: STTK - Get Free Report) and MDxHealth (NASDAQ: MDXH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies…
globenewswire.com Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development – RECEPTIVE-HS1 Phase 2 clinical trial in patients with moderate to severe hidradenitis suppurativa (HS) expected to initiate in 2026; data from the 16-week treatment period expected in the first…
defenseworld.net 3,750,000 Shares in Shattuck Labs, Inc. $STTK Purchased by Frazier Life Sciences Management L.P. Frazier Life Sciences Management L.P. bought a new position in shares of Shattuck Labs, Inc. (NASDAQ: STTK) during the undefined quarter, according to its most recent disclosure with the Securities…
defenseworld.net BlackRock Inc. Invests $27.32 Million in Shattuck Labs, Inc. $STTK BlackRock Inc. purchased a new stake in Shattuck Labs, Inc. (NASDAQ: STTK) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional…
globenewswire.com Shattuck Labs Announces Participation in Upcoming September Investor Conferences AUSTIN, Texas and DURHAM, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of…
seekingalpha.com Shattuck Labs: A Receptor-Side Bet On The TL1A Boom Shattuck Labs pivots to immunology, focusing on DR3-targeted therapies for IBD, notably SL-325, after discontinuing its oncology program. SL-325's Phase 1 data show strong safety, low immunogenicity…
fool.com What Shattuck Labs Stock Topped the Market on Monday One of them initiated coverage. The company has a very promising lead drug candidate.
benzinga.com Raymond James Initiates Coverage On Shattuck Labs with Strong Buy Rating, Announces Price Target of $18 Raymond James analyst Martin Auster initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Strong Buy rating and announces Price Target of $18.
zacks.com Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy? Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.
defenseworld.net Geron (NASDAQ:GERN) and Shattuck Labs (NASDAQ:STTK) Head to Head Comparison Geron (NASDAQ: GERN - Get Free Report) and Shattuck Labs (NASDAQ: STTK - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two…
zacks.com Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade The consensus price target hints at an 85.3% upside potential for Shattuck Labs (STTK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings…
benzinga.com HC Wainwright & Co. Maintains Buy on Shattuck Labs, Lowers Price Target to $14 HC Wainwright & Co. analyst Joseph Pantginis maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $18 to $14.
benzinga.com Shattuck Labs Q2 EPS $(0.12) Misses $(0.10) Estimate Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent increase over losses of $(0.24)…
fool.com Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday He was encouraged by the progress of the company's SL-325. This, the biotech's lead drug candidate, is about to enter Phase 2 clinical testing.
benzinga.com This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…
benzinga.com This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday Wall Street analysts changed outlook on top names. For full changes, upgrades, downgrades and initiations, see analyst ratings page.
247wallst.com Here Are Friday’s Top Wall Street Analyst Research Calls: Albertsons, Blue Owl Capital, Cleveland-Cliffs, Chime Financial, Digital Realty, Dover, PayPal Holdings, SpaceX, and More Markets took a brutal hit Thursday as oil prices, surging interest rates, and Middle East tensions sent every major index deep into the red. See which stocks analysts are upgrading, downgrading, and…
benzinga.com JP Morgan Initiates Coverage On Shattuck Labs with Overweight Rating, Announces Price Target of $10 JP Morgan analyst Brian Cheng initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Overweight rating and announces Price Target of $10.- benzinga.com Leerink Partners Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $16 Leerink Partners analyst Faisal Khurshid initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Outperform rating and announces Price Target of $16.
defenseworld.net Shattuck Labs, Inc. (NASDAQ:STTK) Receives $11.00 Average PT from Brokerages Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has received an average recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the stock, MarketBeat reports. One…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com Rezolve AI, Bakkt, Seagate And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and other stocks such as ALOY and FWRD also rose.
benzinga.com What's Going On With Shattuck Labs Stock Wednesday? Shattuck Labs ($STTK) shares fluctuate after pricing a $75M public offering at $4.00/share. Get the latest stock updates here.
globenewswire.com Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development…
benzinga.com Shattuck Labs Commences Common Stock Offering; Terms Undisclosed Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking…
globenewswire.com Shattuck Labs, Inc. Announces Proposed Public Offering AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development…- benzinga.com Citigroup Maintains Buy on Shattuck Labs, Raises Price Target to $18 Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $7 to $18.
- benzinga.com Shattuck Labs Announces Total Expected Proceeds Of ~$59.4M From Exercised Warrants Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the…
benzinga.com Why Is Shattuck Labs Stock Trading Lower On Monday? Shattuck Labs' stock tumbles after Phase 1 SL-325 data release despite analyst upgrades, a Buy consensus rating, and progress in IBD treatment.
benzinga.com Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech shares rose, communication services fell. Motorcar Parts of America stock jumped 37% on strong…- benzinga.com Needham Maintains Buy on Shattuck Labs, Raises Price Target to $17 Needham analyst Joseph Stringer maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $14 to $17.
- benzinga.com HC Wainwright & Co. Reiterates Buy on Shattuck Labs, Maintains $18 Price Target HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $18 price target.
benzinga.com Shattuck Reports Phase 1 Data for SL-325 Antibody Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potential first-in-class monoclonal and bispecific DR3 blocking…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com Shattuck Labs To Host Investor Call And Webcast On June 8 To Present Comprehensive Phase 1 Clinical Data For SL-325 And Provide Pipeline Update Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the…
benzinga.com Citigroup Upgrades Shattuck Labs to Buy, Announces $7 Price Target Citigroup analyst Yigal Nochomovitz upgrades Shattuck Labs (NASDAQ:STTK) from Neutral to Buy and announces $7 price target.
benzinga.com Merlin, Concrete Pumping Holdings, And Krispy Kreme And Other Big Stocks Moving Higher On Friday U.S. stocks trade lower on Friday, Nasdaq down 425 points. Merlin shares rise 35.93% after successful CDR, other big stocks also record gains.
benzinga.com Concrete Pumping Holdings Reports Blowout Q2 Results, Joins ServiceTitan and Other Big Stocks Moving Higher in Friday's Pre-Market Session US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market. Other stocks moving in pre-market.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Wedbush Maintains Outperform on Shattuck Labs, Raises Price Target to $11 Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and raises the price target from $8 to $11.
benzinga.com Shattuck Labs Q1 EPS $(0.13), Inline Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.13) per share which met the analyst consensus estimate. This is a 51.85 percent increase over losses of $(0.27) per share from the same…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session